RESUMO
We report our initial experience using the intraoperative positioning system (IOPS), a novel endovascular navigation system that does not require contrast or radiation, in the treatment of chronic mesenteric ischemia (CMI). We used IOPS to help treat three of four consecutive patients with CMI. Technical problems prevented successful use in one patient. For the patients for whom IOPS was used effectively, catheterization of the mesenteric artery was accomplished more quickly than for the patient for whom IOPS was not effective. Our experience has shown that IOPS can be safely and effectively used for CMI and can reduce the contrast load and radiation dose.
RESUMO
Wheat (Triticum spp) is one of the first domesticated food crops. It represents the first source of calories (after rice) and an important source of proteins in developing countries. As a result of the Green Revolution, wheat yield sharply increased due to the use of improved varieties, irrigation, pesticides, and fertilizers. The rate of increase in world wheat production, however, slowed after 1980, except in China, India, and Pakistan. Being adapted to a wide range of moisture conditions, wheat is grown on more land area worldwide than any other crop, including in drought prone areas. In these marginal rain-fed environments where at least 60 m ha of wheat is grown, amount and distribution of rainfall are the predominant factors influencing yield variability. Intensive work has been carried out in the area of drought adaptation over the last decades. Breeding strategies for drought tolerance improvement include: definition of the target environment, choice and characterization of the testing environment, water stress management and characterization, and use of phenotyping traits with high heritability. The use of integrative traits, facilitated by the development and application of new technologies (thermal imaging, spectral reflectance, stable isotopes) is facilitating high throughput phenotyping and indirect selection, consequently favoring yield improvement in drought prone environments.
RESUMO
Arid zone of Rajasthan, India, has its own importance, great diversity and specific characteristic with respect to endemic and large number of plants of economic importance and medicinal use. Out of these, three arid zone plants Gisekia pharnaceoides L., Gisekiaceae, Sericostoma pauciflorum Stocks ex Wight, Boraginaceae, and Trianthema decandra L., Aizoaceae, which are traditionally used for different ailments (hepatitis, asthma, jaundice, skin-infections etc.) have been selected for the study. In the present paper, detailed pharmacognostical evaluation of these plant species using microscopy, standard physicochemical determinations and authentic phytochemical parameters has been carried out. Later, these morphological characteristics could be used for rapid identification of the drugs, particularly in case of powdered materials, and may possibly help to differentiate the drug from its other species.
A zona árida de Rajasthan, Índia, é importante pela grande diversidade e especificidade de plantas endêmicas de importância econômica e medicinal. Destas, três plantas de zonas áridas, Gisekia pharnaceoides L., Gisekiaceae, Sericostoma pauciflorum Stocks ex Wight, Boraginaceae, e Trianthema decandra L., Aizoaceae, que são tradicionalmente utilizados para diversas doenças (hepatite, asma, icterícia, infecções da pele etc.), foram selecionados para o estudo. Neste trabalho trabalho, a avaliação farmacognóstica detalhada destas espécies, através de estudo morfoanatômico, determinações físico-químicas e parâmetros fitoquímicos, foram realizados. As características morfológicas podem ser utilizados para rápida identificação das drogas, particularmente no caso de materiais em pó, e possivelmente ajudar a diferenciar a droga de outras espécies.
Assuntos
Doenças do Sistema Nervoso Central/fisiopatologia , Competência Clínica , Glucose/metabolismo , Hipoglicemia/terapia , Triagem Neonatal , Pesquisa Biomédica/organização & administração , Glicemia/análise , Doenças do Sistema Nervoso Central/epidemiologia , Doenças do Sistema Nervoso Central/etiologia , Congressos como Assunto , Medicina Baseada em Evidências , Feminino , Monitorização Fetal , Humanos , Hipoglicemia/complicações , Hipoglicemia/congênito , Recém-Nascido , Masculino , Monitorização Fisiológica , National Institute of Child Health and Human Development (U.S.) , Avaliação das Necessidades , Gravidez , Estados UnidosRESUMO
OBJECTIVES: To examine the effect of supplemental glutamine (0.6 g.kg -1 .d -1 ) on whole body protein/nitrogen and glutamine kinetics in low birth weight (LBW) infants receiving parenteral nutrition in the immediate neonatal period. STUDY DESIGN: Premature infants < or =32 weeks gestation with a birth weight from 694 to 1590 g were randomly assigned to either a glutamine-supplemented group (n = 10) or to a control group (n = 10). Tracer isotope studies were performed when the infants were 6 to 7 days old and had been receiving an amino acid intake of approximately 3.0 g.kg -1 .d -1 for at least 3 days. Whole body glutamine and nitrogen kinetics were measured with [5-15N]glutamine, [2H5]phenylalanine, [1-13C, 15 N]leucine, [15N2]urea, and GC-mass spectrometry. RESULTS: Supplemental glutamine was associated with a lower rate of appearance of glutamine ( P = .003), phenylalanine ( P = .001), and leucine C ( P = .003). There was no significant difference in leucine N turnover, urea turnover and plasma cortisol, and C-reactive protein levels in the 2 groups. CONCLUSION: Parenteral glutamine supplement in LBW infants was associated with lower whole-body protein breakdown. Because the decrease in whole body proteolysis is associated with protein accretion, parenteral glutamine supplement may be beneficial in selected populations of LBW infants.
Assuntos
Aminoácidos/sangue , Glutamina/uso terapêutico , Nutrição Parenteral , Proteínas/metabolismo , Peso ao Nascer , Proteína C-Reativa/metabolismo , Idade Gestacional , Glutamina/metabolismo , Humanos , Hidrocortisona/sangue , Recém-Nascido de Baixo Peso , Recém-Nascido , Cinética , Nitrogênio/metabolismoRESUMO
OBJECTIVE: To determine if docosahexaenoic acid (DHA) and arachidonic acid (ARA) supplementation influences growth or visual acuity of formula-fed premature infants. STUDY DESIGN: Double-blind, multi-center study of 194 premature infants given preterm formula with no DHA or ARA (control), 0.15% energy DHA, or 0.14% DHA + 0.27% ARA from single-cell triglycerides for at least 28 days and then fed term formula (no DHA or ARA) to 57 weeks postmenstrual age (PMA), with 90 breast-fed term infants as reference. RESULTS: Infants fed DHA+ARA formula gained weight significantly faster (post-hoc analysis) during preterm formula feeding than control infants (34.7 vs. 30.7 g/d) and had weights and weight:length ratios not different from term breast-fed infants at 48 and 57 weeks PMA. Infants fed control or DHA formula had lower body weights than term infants. Red blood cell phosphatidylethanolamine ARA was significantly correlated to weight gain during preterm formula feeding and to weight and length at 40, 48, and 57 weeks PMA (r = 0.19 to 0.24, P =.004-.02). Providing DHA or DHA+ARA during the preterm period had no effect on subsequent visual acuity or incidence of adverse events. CONCLUSIONS: Feeding DHA+ARA from single-cell triglycerides enhances weight gain in formula-fed premature infants with no evidence of adverse effects.